Anthony J. Sinskey - May 25, 2022 Form 4 Insider Report for YIELD10 BIOSCIENCE, INC. (YTEN)

Role
Director
Signature
/s/ Megan N. Gates, attorney-in-fact
Stock symbol
YTEN
Transactions as of
May 25, 2022
Transactions value $
$0
Form type
4
Date filed
5/26/2022, 09:17 AM
Previous filing
Apr 4, 2022
Next filing
Jul 1, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction YTEN Stock Option (right to buy) Award $0 +5K $0.00 5K May 25, 2022 Common Stock 5K $2.69 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted to the Reporting Person as the annual option grant to non-employee directors pursuant to the Issuer's Director Compensation Policy for services to be rendered to the Issuer as a member of its Board of Directors.
F2 These options will vest and become exercisable in equal quarterly installments over 4 years from 5/25/2022, beginning on 8/25/2022 and ending on 5/25/2026.